# Safety, Tolerability and Efficacy Study of PP1420 in HV

> **NCT02221765** · PHASE1,PHASE2 · TERMINATED · sponsor: **Imperial College London** · enrollment: 49 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** PP1420
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02221765
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Expected PK\&no safety issues in 1B.1Cwon't proceed due to lack of 1Befficacy
- **Last updated:** 2021-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02221765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02221765, "Safety, Tolerability and Efficacy Study of PP1420 in HV". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02221765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*